Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer.
Vincent P GrootStacy MosierAmmar Asrar JavedJonathan A TeinorGeorgios GemenetzisDing DingLisa M HaleyXin YuRichard A BurkhartAlina HasanainMarija DebeljakHirohiko KamiyamaAmol NarangDaniel A LaheruLei ZhengMing-Tseh LinChristopher D GockeElliot K FishmanRalph H HrubanMichael G GogginsI Quintus MolenaarJohn L CameronMatthew J WeissVictor E VelculescuJin HeChristopher L WolfgangJames R EshlemanPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2019)
Measurement of KRAS ctDNA in a CLIA laboratory setting can be used to predict recurrence and survival in patients with PDAC.